12-week Treatment With Inhaled Tiotropium (18 mcg Once Daily) on Lung Function and Static Lung Volumes in Stable, Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients. Correlation to Dyspnoea Scales

NCT02172378 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

116

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Tiotropium inhalation capsules
DRUG: Placebo inhalation capsules

Sponsor

Boehringer Ingelheim